The switch from ATV/r to unboosted ATV doubles the time of ATV administration.
•
Different toxicity and discontinuation rates have emerged in women and in subjects who switched from ATV/r to unboosted ATV.
•
Therapeutic failure has been significantly related to CD4<200/μL at ATV start and detectable HIV-RNA after 6 months of ATV.
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.